Our Insights
Explore cutting-edge industry insights, trends, and research that
empower pharmaceutical innovation, enhance strategies, and drive
informed decisions globally.
News & Updates
Pharma Outlook Book Feature
Our state-of-the-art facility has been highlighted in the renowned Pharma Outlook Book, a testament to our growing presence and recognition in the international pharmaceutical landscape. This feature underscores our dedication to innovation, compliance, and delivering high-quality pharmaceutical solutions.
CPHI Frankfurt
We are delighted to announce our participation in CPhI Worldwide, Frankfurt, Germany (28-30 October 2025), showcasing our capabilities at the heart of global pharma innovation. Our Stand #12.1A90
Pivotal Clinical Studies
Our pivotal bioequivalence (BE) studies are now available for advanced formulations, including:
Duloxetine HCL EC Pellets 17%
Venlafaxine HCL SR Pellets 33%